Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research

Novamind Expands Leadership Team, Accelerating M&A

Nova Mentis Launches Autism Microbiome Study in the United States

Red Light Holland's iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert

Atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round

Pure Extracts Submits Dealer’s Licence Application to Health Canada

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Psyched Wellness Provides Update on Pre-Clinical Trial of its Muscimol Extract AME-1

Mind Cure Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease

PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization

Optimi Health and Numinus Wellness to Conduct Psychedelic Lab Research and Development

Red Light Holland Launches New Logo and Interactive Wisdom Truffle Companion Created by Internationally Renowned & Award-Winning Designer Karim Rashid

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain